Thursday, December 15, 2005Celerus Diagnostics Raises $2.7MSanta Barbara-based Celerus Diagnostics said yesterday that it has raised $2.7M in Series A funding from private investors. Celerus is developing a rapid cancer diagnostic product. Investors were not disclosed by the company. Celerus said that it is designing an instrument to decentralize testing and move results closer to patients.
posted on Thursday, December 15, 2005 (More)(Full story)
Zag Raises $9M In Series CStealth startup Zag announced yesterday that it has raised a $9M third round of funding from GRP Partners, Capital One, Anthem Ventures, and Arcturus Capital. The firm also revealed in its funding released that it is working on an end to end online auto buying platform for improving the shopping and buying experience for consumers. Zag said that the funding brings the total raised by the company to $32.7M. Zag is headed by CarsDirect founder Scott Painter, who serves as the company's CEO.
posted on Thursday, December 15, 2005 (More)(Full story)
Optimer Pharmaceuticals Announces FundingSan Diego-based Optimer Pharmaceuticals said that it has raised $34.2M in two rounds of venture funding. The latest funding of $22.2M, closed November 30th, and included investments from ProQuest Investments, Lurie Investments, BB Biotech Ventures, SB Life Science Ventures, UOB JAIC Venture Bio Investments, as well as China Development Industrial Bank, ESun Bank Group, Fubon Financial Holding Venture, Global Strategic Investments, Oriental Union Chemical Corp., and Taiwan Global BioFund. The com (More info...)
posted on Thursday, December 15, 2005 (More)(Full story)
Amgen Acquires AbgenixThousand Oaks-based biotech firm Amgen said yesterday that it is acquiring Fremont-based Abgenix for $2.2B. Amgen said that it would pay $22.50 per share in cash of Abgenix stock. Abgenix is a developer of human therapeutic antibodies. Amgen said that it has previously been working with Abgenix on its pipeline product panitumumab, which is targeted at treatment of metastatic colorectal cancer. The companies said that later this week they expect to initiate a biologics license application (BLA) f (More info...)
posted on Thursday, December 15, 2005(Full story)
Experian Buys PriceGrabber For $485MGUS Plc, the parent company of Experian, has acquired Los Angeles-based comparison shopping site PriceGrabber for $485M. GUS said that it will use PriceGrabber to complement Experian's existing operations connecting consumers to companies over the Internet. Pricegrabber employes 140, and was founded in 1999. GUS also said that Pricegrabber will report sales of approximately $60M for the 12 months ending December 2005. PriceGrabber provides comparison shopping services for apparel, electronics, a (More info...)
posted on Thursday, December 15, 2005(Full story)